首页> 外国专利> Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia

Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia

机译:用于治疗或预防高血压并发血清高尿酸血症和/或高胆固醇血症的药物

摘要

The purpose in this invention is to providing drugs for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia that is much frequency among the duplication onset in geriatric diseases. This invention is related to drugs for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia of which active principles are 2-propyl-3- {[2'-(1H-tetrazole -5-yl) biphenyl -4-yl]methyl}-5, 6, 7, 8-tetrahydrocyclohepta imidazole -4-(3H) - one and that prodrug or that salt. Pratosartan is able to use in combination with one or more than two diuretics chosen from sulfonamide-, phenoxyacetic acid- and thiazide-type diuretics, triamterene, amiloride, spironolactone, potassium canrenoate and traxanox sodium. Also, pratosartan is able to use in combination with one or more than two hypolipidemic drugs chosen from statins, fibrates, cholesterol absorption inhibitors, cholesterol sequestrants and cholesterol excretion enhancers.
机译:本发明的目的是提供用于治疗或预防在老年疾病的重复发作中频繁发生的具有血清高尿酸血症和/或高胆固醇血症的高血压重复的药物。本发明涉及用于治疗或预防具有血清高尿酸血症和/或高胆固醇血症的重复高血压的药物,其有效成分为2-丙基-3-{[2'-((1H-四唑-5-基)]联苯-4-基]甲基} -5、6、7、8-四氢环庚咪唑-4-(3H)-一种前药或该盐。普拉托沙坦能够与一种或两种以上的利尿剂联合使用,这些利尿剂选自磺酰胺类,苯氧乙酸类和噻嗪类利尿剂,氨苯蝶啶,阿米洛利,螺内酯,松果酸钾和曲沙诺钠。同样,普拉托沙坦能够与一种或两种以上降血脂药物联合使用,这些药物选自他汀类,贝特类,胆固醇吸收抑制剂,胆固醇螯合剂和胆固醇排泄促进剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号